
INNOTECH
DERMOBACTER CUTANEOUS SOLUTION
Delivery within 3 hours
AI Summary
- Description
- Composition
- Similar products
- More from this brand
- Recipes
Composition. The active substances are benzalkonium chloride and chlorhexidine digluconate. Each ml of cutaneous solution contains benzalkonium chloride 5 mg as benzalkonium chloride 50% solution 9.85 mg and chlorhexidine digluconate 2 mg as chlorhexidine digluconate 20% solution 10.65 mg. The other components are: cocoalkyldimethyl betaine (Amonyl 265BA), Poloxamer 188, hydroxyethylcellulose 10000 mPa.s., citric acid monohydrate, sodium citrate, purified water.
Therapeutic indications.
Dermobacter contains benzalkonium chloride and chlorhexidine digluconate, which are antiseptic substances. Dermobacter is indicated for wound cleansing and as an adjunctive treatment for skin and mucous membrane conditions caused by initial infections or those that may become superinfected.
Dosage and administration.
The solution can be used undiluted or diluted, once or twice a day. - Undiluted use: applied to the skin. - Diluted use 1/10: applied to mucous membranes. The diluted solution must be prepared immediately before use and should not be stored. Administration must always be followed by careful rinsing. In all cases, follow the recommendations made by your doctor or pharmacist.
Precautions.
Use appropriately and do not keep the bottle open for a long period, as microbial contamination is possible once the bottle is opened.
Special warnings.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. During pregnancy, Dermobacter can only be administered if absolutely necessary. It is recommended to apply it to the smallest possible areas, without wounds, without occlusive dressings, and for the shortest possible period. The medicine should not be applied to the breasts during breastfeeding.
Driving and using machines
Dermobacter does not affect the ability to drive or use machines.
Packaging. It is available in boxes with a brown PVC bottle containing 125 ml of cutaneous solution.
Page updated on: 08.06.2021
: Clorura de benzalconiu, digluconat de clorhexidina